Trials / Unknown
UnknownNCT03727828
Diagnostic, Risk Stratification and Prognostic Value of Novel Biomarkers in Patients With Heart Failure
Diagnostic, Risk Stratification and Prognostic Value of Novel Biomarkers in Patients With Heart Failure: DRAGON-HF Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this work is to investigate and then to sequence new biomarkers in the blood of patients with heart failure, and study their diagnostic, risk stratification and prognostic value.
Detailed description
Blood samples (plasma or serum) for heart failure patients presenting dyspnea or edema and with increased NT-proBNP. The objective of this work is to investigate and then to sequence new proteins or microRNAs in the blood of these patients for diagnostic, risk stratification and prognostic purpose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Patients with heart failure | Participants will have serial blood collection on medical therapy for heart failure |
Timeline
- Start date
- 2018-11-15
- Primary completion
- 2020-12-01
- Completion
- 2021-02-28
- First posted
- 2018-11-01
- Last updated
- 2020-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03727828. Inclusion in this directory is not an endorsement.